UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000041744 |
|---|---|
| Receipt number | R000047646 |
| Scientific Title | The gut microbiota of critically ill patients |
| Date of disclosure of the study information | 2020/10/01 |
| Last modified on | 2020/09/09 20:16:44 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The gut microbiota of critically ill patients
Acronym
The gut microbiota of critically ill patients
Scientific Title
The gut microbiota of critically ill patients
Scientific Title:Acronym
The gut microbiota of critically ill patients
Region
| Japan |
Condition
Condition
critically ill patients
Classification by specialty
| Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify changes in intestinal flora
Basic objectives2
Others
Basic objectives -Others
To clarify changes in intestinal flora
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in intestinal flora
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients admitted to ICU
Key exclusion criteria
None
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | Motomu |
| Middle name | |
| Last name | Shimaoka |
Organization
Mie University Graduate School of Medicine
Division name
Dept of Molecular Pathobiology and Cell Adhesion Biology
Zip code
514-8507
Address
2-174 Edobashi Tsu-City
TEL
059-231-5036
motomushimaoka@gmail.com
Public contact
Name of contact person
| 1st name | EIJI |
| Middle name | |
| Last name | KAWAMOTO |
Organization
Mie University Graduate School of Medicine
Division name
Emergency and Disaster Medicine
Zip code
514-8507
Address
2-174 Edobashi, Tsu 514-8507, Japan
TEL
0592321111
Homepage URL
a_2.uk@mac.com
Sponsor or person
Institute
Mie University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
KAKEN
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Mie University Hospital
Address
2-174 Edobashi, Tsu 514-8507, Japan
Tel
059-232-1111
a-2@umin.net
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2016 | Year | 02 | Month | 22 | Day |
Date of IRB
| 2016 | Year | 02 | Month | 22 | Day |
Anticipated trial start date
| 2016 | Year | 02 | Month | 22 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We observe changes in the intestinal microbiota obtained from the stools of patients and changes in the data related to severity and vital signs such as blood data and respiratory circulation data of patients.
Management information
Registered date
| 2020 | Year | 09 | Month | 09 | Day |
Last modified on
| 2020 | Year | 09 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047646
